Abstract:A series of novel multi-substituted coumarin derivatives were synthesized, spectroscopically characterized, and evaluated for their antioxidant activity, soybean lipoxygenase (LOX) inhibitory ability, their influence on cell viability in immortalized human keratinocytes (HaCaT), and cytotoxicity in adenocarcinomic human alveolar basal epithelial cells (A549) and human melanoma (A375) cells, in vitro. Coumarin analogues 4a–4f, bearing a hydroxyl group at position 5 of the coumarin scaffold and halogen substituents at the 3-phenyl ring, were the most promising ABTS•+ scavengers. 6,8-Dibromo-3-(4-hydroxyphenyl)-4-methyl-chromen-2-one (4k) and 6-bromo-3-(4,5-diacetyloxyphenyl)-4-methyl-chromen-2-one (3m) exhibited significant lipid peroxidation inhibitory activity (IC50 36.9 and 37.1 μM). In the DCF-DA assay, the 4′-fluoro-substituted compound 3f (100%), and the 6-bromo substituted compounds 3i (80.9%) and 4i (100%) presented the highest activity. The 3′-fluoro-substituted coumarins 3e and 4e, along with 3-(4-acetyloxyphenyl)-6,8-dibromo-4-methyl-chromen-2-one (3k), were the most potent lipoxygenase (LOX) inhibitors (IC50 11.4, 4.1, and 8.7 μM, respectively) while displaying remarkable hydroxyl radical scavenging ability, 85.2%, 100%, and 92.9%, respectively. In silico docking studies of compounds 4e and 3k, revealed that they present allosteric interactions with the enzyme. The majority of the analogues (100 μΜ) did not affect the cell viability of HaCaT cells, though several compounds presented over 60% cytotoxicity in A549 or A375 cells. Finally, the human oral absorption (%HOA) and plasma protein binding (%PPB) properties of the synthesized coumarins were also estimated using biomimetic chromatography, and all compounds presented high %HOA (>99%) and %PPB (60–97%) values.

5‐Phenylcoumarin Derivatives: Design, Synthesis, and Vasodilatory Activity

Synthesis and Fluorescent Study of 5-Phenyl Furocoumarin Derivatives As Vasodilatory Agents

Synthesis and Biological Evaluation of Novel Biphenyl-Furocoumarin Derivatives As Vasodilator Agents

Design, syntheses, structure-activity relationships and docking studies of coumarin derivatives as novel selective ligands for the CB2 receptor.

Design, Synthesis and Evaluation of 9-Hydroxy-7h-furo[3,2-g]chromen-7-one Derivatives As New Potential Vasodilatory Agents

Design of Novel Thiazole Bearing Pyrazole Derivatives and Their Dual Activities as ACE Inhibitors and Calcium Channel Blockers in Cardiovascular Disease

Design, Synthesis, and Evaluation of New Series of Imperatorin Analogs with Potential Vasodilatory Activity

Synthesis and Vasorelaxation Evaluation of Novel Biphenyl–furocoumarin Derivatives

Synthesis, Characterization and Biological Evaluation of Fluorescent Biphenyl–furocoumarin Derivatives

Research on the synthesis and vasodilatation activity of imperatorin derivatives

Synthesis and Anticancer Evaluation of Novel Coumarin Derivatives

Synthesis, Bioactivity, Pharmacokinetic and Biomimetic Properties of Multi-Substituted Coumarin Derivatives

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Functional Polymers. XXX: 2(2,4,6‐trihydroxyphenyl) 2h‐benzotriazole [2(2h‐benzotriazole‐2‐yl)‐1,3,5‐trihydroxybenzene] and Benzotriazole‐substituted Dihydrocoumarins

Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents.

The angiogenesis-modulating effects of coumarin-derivatives

Flavonoids As Vasorelaxant Agents: Synthesis, Biological Evaluation and Quantitative Structure Activities Relationship (qsar) Studies

Structure-Activity Relationship Studies of Coumarin-like Diacid Derivatives As Human G Protein-Coupled Receptor-35 (hgpr35) Agonists and a Consequent New Design Principle.

Synthesis and Evaluation of New Coumarin Derivatives as Antioxidant, Antimicrobial, and Anti-Inflammatory Agents

Current Developments of Coumarin Compounds in Medicinal Chemistry

Chuanxiongdiolides R4 and R5, phthalide dimers with a complex polycyclic skeleton from the aerial parts of Ligusticum chuanxiong and their vasodilator activity